Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/ASO.2005.01.013
Annals of Surgical Oncology 12:871-880 (2005)
© 2005 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carver, B. S.
Right arrow Articles by Sheinfeld, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carver, B. S.
Right arrow Articles by Sheinfeld, J.

Original Article

Germ Cell Tumors of the Testis

Brett S. Carver, MD and Joel Sheinfeld, MD

Department of Urology, Memorial Sloan-Kettering Cancer Center, 353 East 68th Street, New York, New York 10021

Correspondence: Address correspondence and reprint requests to: Joel Sheinfeld, MD; E-mail: sheinfej{at}mskcc.org.

Testicular cancer is the most common malignancy in men aged 20 to 35 years and accounts for approximately 1% of all male malignancies. Through the appropriate utilization of clinical trials, effective treatment paradigms have been developed for the management of all stages of testicular cancer. The multidisciplinary approach to the management of germ cell tumors of the testis has resulted in survival rates of > 90% overall. This review summarizes the principal management of germ cell tumors of the testis, highlighting the indications for surgery, controversies surrounding the integration of surgery, and alternative management strategies.

Key Words: Testicular cancer • Primary retroperitoneal lymph node dissection • Chemotherapy • Germ cell tumors




This article has been cited by other articles:


Home page
 Eur J EndocrinolHome page
C. Fottner, S. Sattarova, K. Hoffmann, G. Spottl, and M. M Weber
Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers {alpha}-fetoprotein and human chorionic gonadotropin
Eur. J. Endocrinol., September 1, 2008; 159(3): 317 - 327.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
B. S. Carver, A. M. Serio, D. Bajorin, R. J. Motzer, J. Stasi, G. J. Bosl, A. J. Vickers, and J. Sheinfeld
Improved Clinical Outcome in Recent Years for Men With Metastatic Nonseminomatous Germ Cell Tumors
J. Clin. Oncol., December 10, 2007; 25(35): 5603 - 5608.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the Society of Surgical Oncology.